187 related articles for article (PubMed ID: 36096184)
1. Biological characteristics of the Trypanosoma cruzi Arequipa strain make it a good model for Chagas disease drug discovery.
Martín-Escolano R; Rosales MJ; Marín C
Acta Trop; 2022 Dec; 236():106679. PubMed ID: 36096184
[TBL] [Abstract][Full Text] [Related]
2. 4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.
Calvet CM; Choi JY; Thomas D; Suzuki B; Hirata K; Lostracco-Johnson S; de Mesquita LB; Nogueira A; Meuser-Batista M; Silva TA; Siqueira-Neto JL; Roush WR; de Souza Pereira MC; McKerrow JH; Podust LM
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006132. PubMed ID: 29281643
[TBL] [Abstract][Full Text] [Related]
3. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
4. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II).
Campos RF; Guerreiro ML; Sobral Kde S; Lima Rde C; Andrade SG
Rev Soc Bras Med Trop; 2005; 38(2):142-6. PubMed ID: 15821788
[TBL] [Abstract][Full Text] [Related]
5. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
Murta SM; Romanha AJ
Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026
[TBL] [Abstract][Full Text] [Related]
6. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity.
Zingales B; Miles MA; Moraes CB; Luquetti A; Guhl F; Schijman AG; Ribeiro I; ;
Mem Inst Oswaldo Cruz; 2014 Sep; 109(6):828-33. PubMed ID: 25317712
[TBL] [Abstract][Full Text] [Related]
7. Decreased intensity of inflammation in benznidazole-treated mice inoculated with Trypanosoma cruzi I stocks from Mexico and persistence of circulating parasites.
Cruz-Zetina G; del Rio-Rodriguez R; Ramos-Ligonio A; López R; Monteon V
Am J Trop Med Hyg; 2012 Oct; 87(4):671-4. PubMed ID: 22890036
[TBL] [Abstract][Full Text] [Related]
8. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
[TBL] [Abstract][Full Text] [Related]
9. New drug discovery strategies for the treatment of benznidazole-resistance in
Murta SMF; Lemos Santana PA; Jacques Dit Lapierre TJW; Penteado AB; El Hajje M; Navarro Vinha TC; Liarte DB; de Souza ML; Goulart Trossini GH; de Oliveira Rezende Júnior C; de Oliveira RB; Ferreira RS
Expert Opin Drug Discov; 2024 Jun; 19(6):741-753. PubMed ID: 38715393
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon.
Teston APM; Fernandes NS; Abegg CP; de Abreu AP; Sarto MPM; Gomes ML; Toledo MJO
Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
[TBL] [Abstract][Full Text] [Related]
12. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
Cevey ÁC; Mirkin GA; Penas FN; Goren NB
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
Zanusso Junior G; Massago M; Kian D; Toledo MJO
Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
[TBL] [Abstract][Full Text] [Related]
15. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
[TBL] [Abstract][Full Text] [Related]
16. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Fernández MC; González Cappa SM; Solana ME
Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi: Does the intake of nanoencapsulated benznidazole control acute infections?
Dutra da Silva A; Fracasso M; Bottari NB; Gundel S; Ourique AF; Assmann CE; Ferreira DASP; Castro MFV; Reichert KP; de Souza LAF; da Veiga ML; da Rocha MIUM; Monteiro SG; Morsch VM; Chitolina Schetinger MR; da Silva AS
Exp Parasitol; 2023 Jun; 249():108520. PubMed ID: 37001581
[TBL] [Abstract][Full Text] [Related]
20. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ
Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]